Eli Lilly & Co. (LLY) Tops Q2 EPS by 1c; Raises, Narrows FY11 EPS
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,180.16 -2.25%
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.18, $0.01 better than the analyst estimate of $1.17. Revenue for the quarter came in at $6.25 billion versus the consensus estimate of $5.99 billion.
Eli Lilly & Co. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.28.
Eli Lilly & Co. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.28.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lilly files six lawsuits over illegal sales of unapproved retatrutide
- Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
